Small Molecules Acquired in 2021 M&A: Deep Dive

There were 16 acquisitions of companies with small molecule drug assets in 2021 and one merger. Here is a more in-depth look into all of the lead small molecules acquired in 2021, including a review of: 

• The lead molecules in each acquisition and their structural representations where disclosed

• The mechanism of action, stage, and indication of each lead molecule

• Relevant clinical data and rationale for each acquisition